| (1207) Anellovirus: A Novel Marker for Overimmunosuppression and Risk of Infection in Lung Transplant Recipients Y Hamad, A Charya, H Kong, M Jang, T Andargie, P Shah, J Mathew, ... The Journal of Heart and Lung Transplantation 42 (4), S516, 2023 | | 2023 |
| (1228) The Interaction Between CfDNA and Gerd A Cochrane, M Wahl, M Fregoso, M Schreffler, S Nathan, S Aryal The Journal of Heart and Lung Transplantation 42 (4), S524-S525, 2023 | | 2023 |
| (478) Heart-lung Transplantation for Restrictive Cardiomyopathy and Pulmonary Hypertension Due to Emery-Dreifuss Muscular Dystrophy C Thomas, K Klein, J Kennedy, M Psotka, I Isseh, D Tang, S Aryal, ... The Journal of Heart and Lung Transplantation 42 (4), S219, 2023 | | 2023 |
| 1072. SARS-CoV-2 Antibody Levels Associate with Neutrophil Activation S Warner, R Miao, MJ Ramos-Benitez, X Tian, R Reger, PD Burbelo, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 913, 2022 | | 2022 |
| 139 BOS,“DeBos” and “ReBos”: When Is a Drop in the FEV1 Really Permanent? MM Fregoso, R Brenner, J Collen, T Reffett, AW Brown, OA Shlobin, ... The Journal of Heart and Lung Transplantation 30 (4), S53, 2011 | 1 | 2011 |
| 196 Sildenafil to Tadalafil Transition in Patients with Pulmonary Arterial Hypertension: A Retrospective Review OA Shlobin, AW Brown, N Weir, L Merte, S Ahmad, K Brown, SD Nathan The Journal of Heart and Lung Transplantation 30 (4), S72, 2011 | | 2011 |
| 295: Waiting Times and Mortality for IPF Patients Listed for Bilateral or Single Lung Transplantation OA Shlobin, E Edwards, SD Nathan The Journal of Heart and Lung Transplantation 28 (2), S168, 2009 | 3 | 2009 |
| 3 Things You Should Know About Diagnosing and Treating Interstitial Lung Disease S Nathan Medical Economics 97 (15), 66-69, 2020 | | 2020 |
| 410 Impact of elexacaftor/tezacaftor/ivacaftor on blood pressure and BMI in people with CF K Patel, M Mani, J Wilkinson, C Thomas, V Khangoora, S Aryal, C King, ... Journal of Cystic Fibrosis 23, S216-S217, 2024 | | 2024 |
| 6-Minute Walk Distance Effect of Instructions Response SD Nathan, AW Brown, NA Weir CHEST 145 (6), 1440-1441, 2014 | | 2014 |
| 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): confirmation of test performance characteristics SD Nathan, RM Du Bois, C Albera, WZ Bradford, U Costabel, A Kartashov, ... B17. CLINICAL TRIALS IN IDIOPATHIC PULMONARY FIBROSIS: RETHINKING ENDPOINTS …, 2013 | 3 | 2013 |
| 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) S Nathan, C Albera, R du Bois, W Bradford, U Costabel, T King, P Noble, ... European Respiratory Journal 40 (Suppl 56), 2012 | | 2012 |
| A 24-year-old woman with precipitous respiratory failure after lung transplantation WA Warren, D Franco-Palacios, CS King, OA Shlobin, SD Nathan, ... Chest 153 (3), e53-e56, 2018 | 8 | 2018 |
| A 48-year-old south african woman with rheumatoid arthritis and lung nodules M Koslow, SM Bennji, S Griffith-Richards, K Ahmad, GB Johnson, JH Ryu, ... Chest 157 (5), e151-e155, 2020 | 1 | 2020 |
| A critical assessment of treatment options for idiopathic pulmonary fibrosis NR Shah, P Noble, RM Jackson, TE King Jr, SD Nathan, M Padilla, ... Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of …, 2005 | 45 | 2005 |
| A follow-on prospective clinical validation of the Envisia Genomic Classifier MB Scholand, SD Nathan, TV Colby, SD Groshong, DA Lynch, ... A102. ILD DIAGNOSIS AND MONITORING, A2557-A2557, 2020 | 1 | 2020 |
| A molecular classifier that identifies usual interstitial pneumonia in transbronchial biopsy specimens of patients with interstitial lung disease G Raghu, TV Colby, JL Myers, MP Steele, S Benzaquen, K Calero, ... Chest 157 (5), 1391-1392, 2020 | 1 | 2020 |
| A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death M Keller, M Alnababteh, L Ponor, P Shah, J Mathew, R Bower, H Kong, ... The Journal of Heart and Lung Transplantation 43 (4), S33, 2024 | | 2024 |
| A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to … AB Waxman, VF Tapson, PM Smith, C Deng, SD Nathan C69. USE YOUR ILLUSION: NOVEL THERAPEUTIC APPROACHES IN PULMONARY …, 2018 | | 2018 |
| A Multicenter, Retrospective Study of Patients With Pulmonary Arterial Hypertension Who Received Inhaled Iloprost for More Than One Year J McConnell, S Nathan, K Hobbs, D Villanueva, B Hartline, R Frantz Chest 140 (4), 743A, 2011 | | 2011 |
